New research appears to solve a long standing medical mystery by identifying a viral protein, VP16, as the molecular key that prompts herpes simplex virus (HSV) to exit latency and cause recurrent disease. The new study points to a molecular target for designing improved HSV vaccines and treatments.
Filed under: Herpes - Trackback Uri